The occurrence of cervicogenic headache: A mapping review.

Musculoskelet Sci Pract

Musculoskeletal Research Unit, Department of Rehabilitation Sciences, Faculty of Movement and Rehabilitation Sciences, Leuven University, Belgium. Electronic address:

Published: February 2025

Background: Occurrence of cervicogenic headache (CeH), mostly expressed by estimates of the prevalence, ranges between 0.4% and 42%. However, transparency on such estimates is lacking, which hinders generalizing results.

Objective: Mapping the occurrence (expressed by incidence/prevalence) of CeH.

Design: Mapping review.

Method: A systematic literature search of PubMed, EMBASE, Web of Science, Scopus databases (last search update January 28th 2025). The search query comprised terminology relating to "CeH", "prevalence", "incidence".

Results: Thirty-four publications were included (prevalence n = 32, incidence n = 2). The prevalence of CeH varied depending on the geographical location (Norway: 0.17% - USA: 69%), population (age: 0.17%-56.7%, chronic headache: 0.17% - computer users: 64.5%), setting (inpatient: 13.8%-69%, outpatient: 0.38%-10%), diagnostic criteria (International Headache Society: 0.38%-40%, Cervicogenic Headache International Study Group: 0.17%-64.5%), and diagnostic process (questionnaires: 5.3%-64.5%, clinical examination: 0.17%-56.7%, diagnostic block: 0.17%-16.1%).

Conclusion: Most publications were retrieved from Europe, Asia, and the United States. One multicentre study provided results for the African continent. No conclusion could be drawn on the incidence of CeH. The populations studied (e.g., general, age-stratified, specific), settings (e.g., hospital, private practice, clinics, emergency services), diagnostic criteria (e.g., International Headache Society or Cervicogenic Headache International Study Group) and processes (e.g., questionnaires, clinical examination) were heterogeneous. Four publications required a diagnostic block in the diagnostic process. A standardized methodology, especially regarding the diagnostic criteria and process, is needed to compare studies, guarantee quality, and provide estimates to inform policy makers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msksp.2025.103290DOI Listing

Publication Analysis

Top Keywords

cervicogenic headache
16
diagnostic criteria
12
occurrence cervicogenic
8
criteria international
8
international headache
8
headache society
8
headache international
8
international study
8
study group
8
diagnostic process
8

Similar Publications

Protease activated receptor 2 (PAR2) is a G-protein coupled receptor expressed in meningeal neurons, fibroblasts and mast cells that may be targeted to treat migraine. MEDI0618, a fully humanized PAR2 monoclonal antibody, engineered to enhance FcRn-dependent recycling and currently in clinical development, was evaluated in human and rodent in vitro assays, in multiple murine in vivo migraine models and in a model of post-traumatic headache. MEDI0618 bound specifically and with high affinity to cells expressing human PAR2 (hPAR2) and prevented matriptase-induced increase in cytosolic calcium.

View Article and Find Full Text PDF

The occurrence of cervicogenic headache: A mapping review.

Musculoskelet Sci Pract

February 2025

Musculoskeletal Research Unit, Department of Rehabilitation Sciences, Faculty of Movement and Rehabilitation Sciences, Leuven University, Belgium. Electronic address:

Background: Occurrence of cervicogenic headache (CeH), mostly expressed by estimates of the prevalence, ranges between 0.4% and 42%. However, transparency on such estimates is lacking, which hinders generalizing results.

View Article and Find Full Text PDF

Background: Traumatic brain injury (TBI) commonly elicits acute (APTH) and/or persistent (PPTH) post-traumatic headache. Calcitonin gene related peptide (CGRP) has been implicated as a contributor to PTH pathophysiology. We explored the possibility of sexual dimorphism in the effects of CGRP receptor (CGRP-R) blockade in a preclinical model of PTH induced by a mild TBI (mTBI) in male or female mice.

View Article and Find Full Text PDF

Objective: To interrogate brain iron accumulation using magnetic resonance T imaging in acute post-traumatic headache (PTH) due to mild traumatic brain injury (mTBI) and to examine associations between iron accumulation with headache frequency, number of mTBIs, post-concussion symptom severity, and time since TBI.

Background: We hypothesized that brain iron accumulation, a marker of neural injury, would be present in PTH and that it would correlate with measures of PTH and mTBI severity.

Design/methods: Sixty participants with acute PTH and 60 age-matched healthy controls (HC) underwent 3T brain magnetic resonance imaging (T maps).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!